GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iCo Therapeutics Inc (GREY:ICOTF) » Definitions » Inventory-to-Revenue

iCo Therapeutics (iCo Therapeutics) Inventory-to-Revenue : 0.00 (As of Mar. 2021)


View and export this data going back to 2009. Start your Free Trial

What is iCo Therapeutics Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. iCo Therapeutics's Average Total Inventories for the quarter that ended in Mar. 2021 was $0.00 Mil. iCo Therapeutics's Revenue for the three months ended in Mar. 2021 was $0.00 Mil.

iCo Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2021 stayed the same from Dec. 2020 (0.00) to Dec. 2020 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


iCo Therapeutics Inventory-to-Revenue Historical Data

The historical data trend for iCo Therapeutics's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iCo Therapeutics Inventory-to-Revenue Chart

iCo Therapeutics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

iCo Therapeutics Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of iCo Therapeutics's Inventory-to-Revenue

For the Biotechnology subindustry, iCo Therapeutics's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iCo Therapeutics's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, iCo Therapeutics's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where iCo Therapeutics's Inventory-to-Revenue falls into.



iCo Therapeutics Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

iCo Therapeutics's Inventory-to-Revenue for the fiscal year that ended in Dec. 2020 is calculated as

Inventory-to-Revenue (A: Dec. 2020 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2019 ) + Total Inventories (A: Dec. 2020 )) / count ) / Revenue (A: Dec. 2020 )
=( (0 + 0) / 1 ) / 0
=0 / 0
=N/A

iCo Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2021 is calculated as

Inventory-to-Revenue (Q: Mar. 2021 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2020 ) + Total Inventories (Q: Mar. 2021 )) / count ) / Revenue (Q: Mar. 2021 )
=( (0 + 0) / 1 ) / 0
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iCo Therapeutics  (GREY:ICOTF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

iCo Therapeutics's Days Inventory for the three months ended in Mar. 2021 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2021 )/Cost of Goods Sold (Q: Mar. 2021 )*Days in Period
=0/0*365 / 4
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

iCo Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2021 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2021 ) / Average Total Inventories (Q: Mar. 2021 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iCo Therapeutics Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of iCo Therapeutics's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


iCo Therapeutics (iCo Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
777 Hornby Street, 6th Floor, Vancouver, BC, CAN, V6Z 1S4
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

iCo Therapeutics (iCo Therapeutics) Headlines

No Headlines